Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 40

1.

Recent Development of Visceral Leishmaniasis Treatments: Successes, Pitfalls, and Perspectives.

Alves F, Bilbe G, Blesson S, Goyal V, Monnerat S, Mowbray C, Muthoni Ouattara G, Pécoul B, Rijal S, Rode J, Solomos A, Strub-Wourgaft N, Wasunna M, Wells S, Zijlstra EE, Arana B, Alvar J.

Clin Microbiol Rev. 2018 Aug 29;31(4). pii: e00048-18. doi: 10.1128/CMR.00048-18. Print 2018 Oct. Review.

PMID:
30158301
2.

[An alternative and innovative Research and Development model to ensure access to medicines - Neglected diseases, neglected populations, and biomedical innovation system].

Pécoul B.

Med Sci (Paris). 2016 Dec;32(12):1049-1050. doi: 10.1051/medsci/20163212001. Epub 2017 Jan 3. French. No abstract available.

3.

Essential medicines for universal health coverage.

Wirtz VJ, Hogerzeil HV, Gray AL, Bigdeli M, de Joncheere CP, Ewen MA, Gyansa-Lutterodt M, Jing S, Luiza VL, Mbindyo RM, Möller H, Moucheraud C, Pécoul B, Rägo L, Rashidian A, Ross-Degnan D, Stephens PN, Teerawattananon Y, 't Hoen EF, Wagner AK, Yadav P, Reich MR.

Lancet. 2017 Jan 28;389(10067):403-476. doi: 10.1016/S0140-6736(16)31599-9. Epub 2016 Nov 8. Review. No abstract available.

PMID:
27832874
4.

Eliminating the Neglected Tropical Diseases: Translational Science and New Technologies.

Hotez PJ, Pecoul B, Rijal S, Boehme C, Aksoy S, Malecela M, Tapia-Conyer R, Reeder JC.

PLoS Negl Trop Dis. 2016 Mar 2;10(3):e0003895. doi: 10.1371/journal.pntd.0003895. eCollection 2016 Mar. Review.

5.

The BENEFIT Trial: Where Do We Go from Here?

Pecoul B, Batista C, Stobbaerts E, Ribeiro I, Vilasanjuan R, Gascon J, Pinazo MJ, Moriana S, Gold S, Pereiro A, Navarro M, Torrico F, Bottazzi ME, Hotez PJ.

PLoS Negl Trop Dis. 2016 Feb 25;10(2):e0004343. doi: 10.1371/journal.pntd.0004343. eCollection 2016 Feb. No abstract available.

6.

A global biomedical R&D fund and mechanism for innovations of public health importance.

Balasegaram M, Bréchot C, Farrar J, Heymann D, Ganguly N, Khor M, Lévy Y, Matsoso P, Minghui R, Pécoul B, Peilong L, Tanner M, Røttingen JA.

PLoS Med. 2015 May 11;12(5):e1001831. doi: 10.1371/journal.pmed.1001831. eCollection 2015 May. No abstract available.

7.

The drug and vaccine landscape for neglected diseases (2000-11): a systematic assessment.

Pedrique B, Strub-Wourgaft N, Some C, Olliaro P, Trouiller P, Ford N, Pécoul B, Bradol JH.

Lancet Glob Health. 2013 Dec;1(6):e371-9. doi: 10.1016/S2214-109X(13)70078-0. Epub 2013 Oct 24. Review.

8.

WHO: Steering plans for neglected diseases.

Pécoul B, Balasegaram M.

Nature. 2014 Mar 27;507(7493):431. doi: 10.1038/507431d. No abstract available.

PMID:
24670749
9.

An unfolding tragedy of Chagas disease in North America.

Hotez PJ, Dumonteil E, Betancourt Cravioto M, Bottazzi ME, Tapia-Conyer R, Meymandi S, Karunakara U, Ribeiro I, Cohen RM, Pecoul B.

PLoS Negl Trop Dis. 2013 Oct 31;7(10):e2300. doi: 10.1371/journal.pntd.0002300. eCollection 2013. Review. No abstract available.

10.

Human African trypanosomiasis in the Democratic Republic of the Congo: a looming emergency?

Hasker E, Lutumba P, Chappuis F, Kande V, Potet J, De Weggheleire A, Kambo C, Depoortere E, Pécoul B, Boelaert M.

PLoS Negl Trop Dis. 2012;6(12):e1950. doi: 10.1371/journal.pntd.0001950. Epub 2012 Dec 13. No abstract available.

11.

Ask the experts.

Pecoul B, Pollastri M, McKerrow J, Bueno-Calderon JM.

Future Med Chem. 2012 Jul;4(11):1383-9. doi: 10.4155/fmc.12.82.

PMID:
22857528
12.

Pediatric HIV--a neglected disease?

Lallemant M, Chang S, Cohen R, Pecoul B.

N Engl J Med. 2011 Aug 18;365(7):581-3. doi: 10.1056/NEJMp1107275. No abstract available.

13.

[Management of neglected diseases: efficacy of an innovative approach].

Pécoul B.

Rev Med Suisse. 2011 Apr 27;7(292):928-9. French. No abstract available.

PMID:
21674898
14.

Innovative public-private partnerships to maximize the delivery of anti-malarial medicines: lessons learned from the ASAQ Winthrop experience.

Bompart F, Kiechel JR, Sebbag R, Pecoul B.

Malar J. 2011 May 23;10:143. doi: 10.1186/1475-2875-10-143.

15.

Registering new drugs for low-income countries: the African challenge.

Moran M, Strub-Wourgaft N, Guzman J, Boulet P, Wu L, Pecoul B.

PLoS Med. 2011 Feb;8(2):e1000411. doi: 10.1371/journal.pmed.1000411. Epub 2011 Feb 1. No abstract available.

16.

Fexinidazole--a new oral nitroimidazole drug candidate entering clinical development for the treatment of sleeping sickness.

Torreele E, Bourdin Trunz B, Tweats D, Kaiser M, Brun R, Mazué G, Bray MA, Pécoul B.

PLoS Negl Trop Dis. 2010 Dec 21;4(12):e923. doi: 10.1371/journal.pntd.0000923.

17.

"Manifesto" for advancing the control and elimination of neglected tropical diseases.

Hotez PJ, Pecoul B.

PLoS Negl Trop Dis. 2010 May 25;4(5):e718. doi: 10.1371/journal.pntd.0000718. No abstract available. Erratum in: PLoS Negl Trop Dis. 2010;4(5). doi: 10.1371/annotation/53d95072-6329-412d-a5e4-c1a00acd1934.

18.

Anti-malarial market and policy surveys in sub-Saharan Africa.

Diap G, Amuasi J, Boakye I, Sevcsik AM, Pecoul B.

Malar J. 2010 Apr 23;9 Suppl 1:S1. doi: 10.1186/1475-2875-9-S1-S1.

19.

New, improved treatments for Chagas disease: from the R&D pipeline to the patients.

Ribeiro I, Sevcsik AM, Alves F, Diap G, Don R, Harhay MO, Chang S, Pecoul B.

PLoS Negl Trop Dis. 2009 Jul 7;3(7):e484. doi: 10.1371/journal.pntd.0000484. Review. No abstract available.

20.

Interview with Dr Bernard Pécoul, Executive Director of the Drugs for Neglected Diseases Initiative.

Pécoul B.

Future Med Chem. 2009 May;1(2):243-8. doi: 10.4155/fmc.09.32.

21.

Research in complex humanitarian emergencies: the Médecins Sans Frontières/Epicentre experience.

Brown V, Guerin PJ, Legros D, Paquet C, Pécoul B, Moren A.

PLoS Med. 2008 Apr 15;5(4):e89. doi: 10.1371/journal.pmed.0050089. No abstract available.

22.

[ASAQ, a breakthrough in the fight against malaria].

Kiechel JR, Pécoul B.

Med Trop (Mars). 2007 Apr;67(2):109-10. French. No abstract available.

PMID:
17691424
23.

Government action needed to step up research and development for world's most neglected diseases.

Pecoul B.

Expert Rev Anti Infect Ther. 2005 Dec;3(6):841-3. No abstract available.

PMID:
16307495
24.

Simplifying and adapting antiretroviral treatment in resource-poor settings: a necessary step to scaling-up.

Calmy A, Klement E, Teck R, Berman D, Pécoul B, Ferradini L.

AIDS. 2004 Dec 3;18(18):2353-60. Review. No abstract available.

PMID:
15622311
25.

New drugs for neglected diseases: from pipeline to patients.

Pécoul B.

PLoS Med. 2004 Oct;1(1):e6. Epub 2004 Oct 19. No abstract available.

26.

Do patents prevent access to drugs for HIV in developing countries?

Goemaere E, Kaninda AV, Ciaffi L, Mulemba M, t Hoen E, Pécoul B.

JAMA. 2002 Feb 20;287(7):841-2; author reply 842-3. No abstract available.

PMID:
11851569
27.

Availability and affordability of treatment for Human African Trypanosomiasis.

Etchegorry MG, Helenport JP, Pecoul B, Jannin J, Legros D.

Trop Med Int Health. 2001 Nov;6(11):957-9.

28.

Drugs for neglected diseases: a failure of the market and a public health failure?

Trouiller P, Torreele E, Olliaro P, White N, Foster S, Wirth D, Pécoul B.

Trop Med Int Health. 2001 Nov;6(11):945-51. Review.

29.

Public health. Responding to market failures in tuberculosis control.

Gupta R, Kim JY, Espinal MA, Caudron JM, Pecoul B, Farmer PE, Raviglione MC.

Science. 2001 Aug 10;293(5532):1049-51. Epub 2001 Jul 19. No abstract available.

PMID:
11463877
30.

[Drugs for 'neglected diseases': a bitter pill].

Veeken H, Pécoul B.

Ned Tijdschr Geneeskd. 2000 Jun 24;144(26):1253-6. Review. Dutch.

PMID:
10908954
31.

Drugs for 'neglected diseases': a bitter pill.

Veeken H, Pécoul B.

Trop Med Int Health. 2000 May;5(5):309-11. No abstract available. Erratum in: Trop Med Int Health 2000 Aug;5(8):590.

32.

Production of sleeping-sickness treatment.

Pécoul B, Gastellu M.

Lancet. 1999 Sep 11;354(9182):955-6. No abstract available.

PMID:
10489988
33.

Is orphan drug status beneficial to tropical disease control? Comparison of the American and future European orphan drug acts.

Trouiller P, Battistella C, Pinel J, Pecoul B.

Trop Med Int Health. 1999 Jun;4(6):412-20.

34.

Access to essential drugs in poor countries: a lost battle?

Pécoul B, Chirac P, Trouiller P, Pinel J.

JAMA. 1999 Jan 27;281(4):361-7.

PMID:
9929090
35.

Permethrin-impregnated bed nets for the prevention of malaria in schoolchildren on the Thai-Burmese border.

Luxemburger C, Perea WA, Delmas G, Pruja C, Pecoul B, Moren A.

Trans R Soc Trop Med Hyg. 1994 Mar-Apr;88(2):155-9.

PMID:
8036656
36.

Efficacy of a therapeutic feeding centre evaluated during hospitalization and a follow-up period, Tahoua, Niger, 1987-1988.

Pécoul B, Soutif C, Hounkpevi M, Ducos M.

Ann Trop Paediatr. 1992;12(1):47-54.

PMID:
1376587
37.

Malaria surveillance among the displaced Karen population in Thailand April 1984 to February 1989, Mae Sot, Thailand.

Decludt B, Pecoul B, Biberson P, Lang R, Imivithaya S.

Southeast Asian J Trop Med Public Health. 1991 Dec;22(4):504-8.

PMID:
1820635
38.

Long-acting chloramphenicol versus intravenous ampicillin for treatment of bacterial meningitis.

Pécoul B, Varaine F, Keita M, Soga G, Djibo A, Soula G, Abdou A, Etienne J, Rey M.

Lancet. 1991 Oct 5;338(8771):862-6.

PMID:
1681224
39.

[Risk factors for malnutrition in 0-59-month-old infants in 2 districts of Niger].

Quelin G, Pecoul B, Amadou B, Baker S.

Med Trop (Mars). 1991 Jul-Sep;51(3):335-42. French.

PMID:
1943645
40.

Mortality trends among refugees in Honduras, 1984-1987.

Desenclos JC, Michel D, Tholly F, Magdi I, Pecoul B, Desve G.

Int J Epidemiol. 1990 Jun;19(2):367-73.

PMID:
2376449

Supplemental Content

Loading ...
Support Center